Globus Medical (GMED) Receives a Buy from Barclays
In a report released today, Matt Miksic from Barclays maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target ...
Zacks.com on MSN1d
Globus Medical (GMED) Reports Next Week: Wall Street Expects Earnings Growth
Globus Medical (GMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Globus Medical to buy Nevro in $250M all-cash deal
Globus Medical (GMED) has agreed to buy Nevro (NVRO) through an all-cash deal valued at around $250M. Read more here.
Becker's Spine Review8d
Globus Medical to acquire spine company for $250M
Globus Medical is acquiring Nevro Corp, a spinal cord stimulator company, according to a Feb. 6 news release. Globus Medical's transaction will include all shares of Nevro, which are valued at about ...
Globus Medical (GMED) Receives a Hold from Needham
In a report released today, David Saxon from Needham maintained a Hold rating on Globus Medical (GMED – Research Report). The company’s shares ...
Nasdaq8d
Globus Medical to Acquire Nevro Corp. in All-Cash Transaction Valued at $250 Million
Globus Medical will acquire Nevro for $250 million in cash, enhancing its musculoskeletal technology portfolio andglobal marketreach. Globus Medical and Nevro Corp. have agreed on an all-cash ...
The Globe and Mail6d
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients
AUDUBON, Pa. and REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp ...
Yahoo Finance15d
Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
About Globus Medical, Inc. Based in Audubon ... Safe Harbor Statements All statements included in this press release other than statements of historical fact are forward-looking statements and may be ...